June 20, 2018

Two Finnish innovators land funding

GrainSense developed the world's first handheld device for measuring grain quality. The product is now attracting interest in Northern Europe.
GrainSense developed the world's first handheld device for measuring grain quality. The product is now attracting interest in Northern Europe.
Rickard Lindgren/Agency Leroy

Healthtech company Emfit has secured 430 000 euros in funding as part of the EU-funded Nightingale project, while agritech startup GrainSense has closed a 1.9 million-euro funding round.

Emfit is among the four companies chosen to produce prototypes for the second phase of the Nightingale project, a EU-funded pre-commercial procurement initiative that develops wearable technology for the continuous health monitoring of patients, both in and out of hospital.

The selection was done by a consortium of five leading European university hospitals, which will offer commercial growth opportunities for Emfit. The best two solutions will also go on to the final phase of the Nightingale project, which will commence in the spring of 2019.

Emfit’s solution enables round-the-clock health monitoring with a wearable device that measures health indicators such as skin temperature, breathing rate, pulse, blood pressure and activity, while AI and machine learning algorithms help ensure that health deterioration is detected early on.

Meanwhile, Finnish agritech startup GrainSense has closed a 1.9 million-euro funding round, with participation from two new private Nordic investors, as well as previous investors in the company.

The Finnish startup will use the funding to build its sales network in Europe, and to further develop its cloud services, digital environment and streamlined supply chain.

GrainSense’s product is a handheld device that measures the levels of protein, moisture, oil and carbohydrates in a grain, in a matter of seconds. After a long development phase the product is on the market, with sales in Finland, Sweden and the Baltic countries so far.

Share: